Acorda Therapeutics, Inc. (ACOR) Statistics & Valuation Metrics

Total Valuation

ACOR has a market cap or net worth of $18.08 million. The enterprise value is $170.59 million.

Market Cap	18.08M
Enterprise Value	170.59M

Important Dates

The last earnings date was Monday, November 13, 2023, after market close.

Earnings Date	Nov 13, 2023
Ex-Dividend Date	n/a

Share Statistics

ACOR has 1.20 million shares outstanding. The number of shares has increased by 0.16% in one year.

Shares Outstanding	1.20M
Shares Change (YoY)	+0.16%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.69%
Owned by Institutions (%)	13.38%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.16
Forward PS	n/a
PB Ratio	0.31
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.54
EV / EBITDA	3.86
EV / EBIT	13.70
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.59, with a Debt / Equity ratio of 3.16.

Current Ratio	1.59
Quick Ratio	0.98
Debt / Equity	3.16
Debt / EBITDA	4.21
Debt / FCF	n/a
Interest Coverage	0.40

Financial Efficiency

Return on equity (ROE) is -21.50% and return on invested capital (ROIC) is -8.34%.

Return on Equity (ROE)	-21.50%
Return on Assets (ROA)	-4.20%
Return on Capital (ROIC)	-8.34%
Revenue Per Employee	$1.00M
Profits Per Employee	-$143,703
Employee Count	111
Asset Turnover	0.30
Inventory Turnover	0.86

Taxes

Income Tax	-2.63M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.39% in the last 52 weeks. The beta is 1.39, so ACOR's price volatility has been higher than the market average.

Beta (1Y)	1.39
52-Week Price Change	+13.39%
50-Day Moving Average	11.41
200-Day Moving Average	12.70
Relative Strength Index (RSI)	64.11
Average Volume (30 Days)	6,253

Short Selling Information

The latest short interest is 13,096, so 1.09% of the outstanding shares have been sold short.

Short Interest	13,096
Short Previous Month	16,643
Short % of Shares Out	1.09%
Short % of Float	n/a
Short Ratio (days to cover)	2.59

Income Statement

In the last 12 months, ACOR had revenue of $111.12 million and -$15.95 million in losses. Loss per share was -$1.51.

Revenue	111.12M
Gross Profit	96.87M
Operating Income	-20.43M
Pretax Income	-18.58M
Net Income	-15.95M
EBITDA	44.18M
EBIT	12.45M
Loss Per Share	-$1.51

Full Income Statement

Balance Sheet

The company has $33.58 million in cash and $186.09 million in debt, giving a net cash position of -$152.51 million or -$127.28 per share.

Cash & Cash Equivalents	33.58M
Total Debt	186.09M
Net Cash	-152.51M
Net Cash Per Share	-$127.28
Equity / Book Value	58.96M
Book Value Per Share	49.20
Working Capital	27.43M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$1.90 million and capital expenditures -$220,000, giving a free cash flow of -$2.12 million.

Operating Cash Flow	-1.90M
Capital Expenditures	-220,000
Free Cash Flow	-2.12M
FCF Per Share	-$1.71

Full Cash Flow Statement

Margins

Gross margin is 87.18%, with operating and profit margins of -18.38% and -14.36%.

Gross Margin	87.18%
Operating Margin	-18.38%
Pretax Margin	-16.72%
Profit Margin	-14.36%
EBITDA Margin	39.76%
EBIT Margin	11.20%
FCF Margin	-1.91%

Dividends & Yields

ACOR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Earnings Yield	-88.22%
FCF Yield	-11.72%
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Buyback Yield	-0.16%
Shareholder Yield	-0.16%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on June 5, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date	Jun 5, 2023
Split Type	Reverse
Split Ratio	1:20

Scores

ACOR has an Altman Z-Score of -3.17 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.17
Piotroski F-Score	3